These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12760184)
1. Nonvalvular atrial fibrillation: an important cause of stroke. Bornstein NM; Pavlovic AM Adv Neurol; 2003; 92():203-12. PubMed ID: 12760184 [No Abstract] [Full Text] [Related]
3. Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice. Laguna P; Martín A; Del Arco C; Millán I; Gargantilla P; Acad Emerg Med; 2005 Sep; 12(9):828-34. PubMed ID: 16141016 [TBL] [Abstract][Full Text] [Related]
4. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation? Robertson SL; Mayer JB; Guthmann R J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100 [No Abstract] [Full Text] [Related]
5. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here? Go AS Nat Clin Pract Cardiovasc Med; 2005 May; 2(5):226-7. PubMed ID: 16265488 [No Abstract] [Full Text] [Related]
7. Anticoagulation: stroke prevention in patients with atrial fibrillation. Waldo AL Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation: stroke prevention in patients with atrial fibrillation. Waldo AL Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769 [TBL] [Abstract][Full Text] [Related]
9. Stroke prevention in nonvalvular atrial fibrillation: update on target-specific oral anticoagulants. Patrick C; Clarke R J Contin Educ Nurs; 2015 Apr; 46(4):152-4. PubMed ID: 25856447 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities. Lip GY Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489 [No Abstract] [Full Text] [Related]
13. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely. Watson T; Kakar P; Lip GY Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172 [No Abstract] [Full Text] [Related]
14. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients]. Reicke B; Masuhr F; Weih M Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772 [TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in general practice. Lip GY Practitioner; 1999 Oct; 243(1603):746-51. PubMed ID: 10715873 [No Abstract] [Full Text] [Related]
16. Lost life years attributable to stroke among patients with nonvalvular atrial fibrillation: a nationwide population-based follow-up study. Frost L; Andersen LV; Johnsen SP; Mortensen LS Neuroepidemiology; 2007; 29(1-2):59-65. PubMed ID: 17925595 [TBL] [Abstract][Full Text] [Related]
17. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation. Jolobe OM J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207 [No Abstract] [Full Text] [Related]
18. Clinical benefit of early anticoagulation in cardioembolic stroke. Micheli S; Agnelli G; Caso V; Paciaroni M Cerebrovasc Dis; 2008; 25(4):289-96. PubMed ID: 18303246 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. Hylek EM; Becker RC Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369 [No Abstract] [Full Text] [Related]
20. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected. Taggar JS; Lip GY Europace; 2008 Jan; 10(1):1-2. PubMed ID: 17906285 [No Abstract] [Full Text] [Related] [Next] [New Search]